Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression

被引:33
|
作者
Zhang, HG
Bilbao, G
Zhou, T
Contreras, JL
Gómez-Navarro, J
Feng, MZ
Saito, I
Mountz, JD
Curiel, DT
机构
[1] Univ Alabama, Gene Therapy Program, Dept Rheumatol, Birmingham, AL 35294 USA
[2] Univ Alabama, Gene Therapy Program, Dept Surg, Birmingham, AL 35294 USA
[3] Univ Tokyo, Inst Med Sci, Genet Mol Lab, Tokyo, Japan
关键词
D O I
10.1128/JVI.72.3.2483-2490.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
An adenovirus vector encoding murine Fas ligand (mFasL) under an inducible control was derived. In vivo ectopic expression of mFasL in murine livers induced an inflammatory cellular infiltration. Furthermore, ectopic expression of mFasL by myocytes did not allow prolonged vector-mediated transgene expression. Thus, ectopic expression of functional mFasL in vector-transduced cells does not appear to confer, by itself, an immunoprivileged site sufficient to mitigate adenovirus vector immunogenicity.
引用
收藏
页码:2483 / 2490
页数:8
相关论文
共 50 条
  • [1] Construction of a recombinant adenovirus vector encoding Fas ligand with a CRE/loxp inducible system
    Bilbao, G
    Zhang, H
    Contreras, JL
    Zhou, T
    Feng, M
    Saito, I
    Mountz, JD
    Curiel, DT
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 792 - 793
  • [2] Systemic vector leakage and transgene expression by intratumorally injected recombinant adenovirus vectors
    Lohr, F
    Huang, Q
    Hu, K
    Dewhirst, MW
    Li, CY
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3625 - 3628
  • [3] Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus
    CS Stein
    JL Pemberton
    N van Rooijen
    BL Davidson
    Gene Therapy, 1998, 5 : 431 - 439
  • [4] Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus
    Stein, CS
    Pemberton, JL
    van Rooijen, N
    Davidson, BL
    GENE THERAPY, 1998, 5 (04) : 431 - 439
  • [5] Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression
    Schowalter, DB
    Meuse, L
    Wilson, CB
    Linsley, PS
    Kay, MA
    GENE THERAPY, 1997, 4 (08) : 853 - 860
  • [6] Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression
    DB Schowalter
    L Meuse
    CB Wilson
    PS Linsley
    MA Kay
    Gene Therapy, 1997, 4 : 853 - 860
  • [7] On/off switching fas-ligand gene expression in liver by Cre/Loxp adenovirus vector system
    Fujino, M
    Li, XK
    Okuyama, T
    Funeshima, N
    Tamura, A
    Enosawa, S
    Kita, Y
    Amano, T
    Yamada, M
    Amemiya, H
    Suzuki, S
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 753 - 754
  • [8] Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector
    Xu, ZL
    Mizuguchi, H
    Ishii-Watabe, A
    Uchida, E
    Mayumi, T
    Hayakawa, T
    JOURNAL OF CONTROLLED RELEASE, 2002, 81 (1-2) : 155 - 163
  • [9] Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle
    Seidman, MA
    Hogan, SM
    Wendland, RL
    Worgall, S
    Crystal, RG
    Leopold, PL
    MOLECULAR THERAPY, 2001, 4 (01) : 13 - 21
  • [10] Adenoviral vector-mediated gene therapy in the mouse lung: No role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells
    Chirmule, N
    Moffett, J
    Dhagat, P
    Tazelaar, J
    Wilson, JM
    HUMAN GENE THERAPY, 1999, 10 (17) : 2839 - 2846